NEW COMMENT—Revisiting safety and refining benefit of rituximab–belimumab combination for refractory #SLE bit.ly/4hWxegq #Medsky #Rheumsky

NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm Plus, linked Comment bit.ly/4hOOOmz #Medsky #Rheumsky

Our December issue is out now at www.thelancet.com/journals/lan... Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more! #GastroSky #LiverSky #MedSky

👉 Register now: hubs.li/Q03NdTNP0 📆 Nov 20, 2025 | 2pm GMT / 9am EST / 10pm CST Join our expert panel as they explore innate immunity’s role in neurological diseases, and therapies to prevent inflammation-driven neurodegeneration. #neurology #brainhealth #lancetwebinar

NEW in @thelancet.com—Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial bit.ly/47CKHoN Plus, linked Comment bit.ly/4oJVcgV #Medsky #Rheumsky

🔥Hot off the press for #ACR25 🔥 Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm Plus, linked Comment bit.ly/4300NHF #Medsky #Rheumsky

NEW RESEARCH—Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA bit.ly/3L1F0t5 @jeffsparks.bsky.social

Severe #glucocorticoid-induced #osteoporosis requires a long-term sequential treatment approach consisting of a bone anabolic agent followed by an antiresorptive drug www.thelancet.com/journals/lan... #OpenAccess #MedSky #EndoSky #RheumSky

Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky

NEW—The Nobel celebrates tolerance News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social

NEW Profile—Sharon Dowell: specialised treatment for the many bit.ly/4owCwkL #Medsky #Rheumsky

Our November issue is live! Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0

Want to stay up to date with the latest original research, perspectives and insights in your field? 🏥 Explore our Specialty Collections to stay informed with the most current and relevant content published across The Lancet Group. 🔗 thelancet.com/collections

ICYMI

NEW REVIEW—Synovial immunopathology in psoriatic arthritis: cellular and molecular insights bit.ly/4pKi9Su #Medsky #Rheumsky

NEW RESEARCH—Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study bit.ly/3W2mXVX #Medsky #Rheumsky

NEW podcast episode🎧 Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis Apple: bit.ly/3VBBXcZ Spotify: bit.ly/47W9TbI Full Article: bit.ly/4nk2rfd #Medsky #Rheumsky #Biomechsky

Join Zoë Mullan and other Lancet Group editors to learn more about the SAGER guidelines for sex- and gender-based analyses, explore real research examples, and gain practical tips for responding to the guidelines. 📅 21 October, 2pm BST 👉 Register: hubs.li/Q03FQ_6l0

Our October issue is live! Including research on #vaccination in #rheumatoidarthritis and #hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

NEW RESEARCH—The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 bit.ly/4mhrbDx #Medsky #Rheumsky #GBDStudy @ihmeuw.bsky.social

NEW—Unscientific vaccine policy endangers vulnerable patients Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky

Our inaugural issue is out now! 🎉 Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0 Thank you to our authors and reviewers! #medsky #physician-researcher #obgynsky #womenshealthsky

NEW RESEARCH—Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data bit.ly/4mc76P1 #Medsky #Rheumsky

NEW COMMENT—Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease bit.ly/46xopoY #Medsky #Rheumsky

NEW RESEARCH—Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial bit.ly/4nrPIqK #JIA #Medsky #Rheumsky

NEW—Two Reviews on VEXAS syndrome, a disorder caused by an acquired monogenic somatic UBA1 gene mutation which affects ubiquitination and triggers immune dysregulation, leading to diverse clinical and pathological features resembling inflammatory rheumatic diseases #Medsky #Rheumsky #Heamsky

NEW RESEARCH—Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids vs methotrexate and corticosteroids in early, untreated #psoriaticarthritis bit.ly/465KoSC @drailyntan.bsky.social @universityofleeds.bsky.social @nihrleedsbrc.bsky.social #Rheumsky #Medsky

NEW Correspondence—Further progression in patients with systemic sclerosis-associated interstitial lung disease Letter ➡️https://bit.ly/45KZm1v Authors' reply ➡️https://bit.ly/3JKrfhy Linked to this Article ➡️https://bit.ly/4gbwFi0 #Medsky #Rheumsky

📢Calling all aspiring rheumatologists in Sub-Saharan Africa! #EULAR and #AFLAR are enhancing #rheumatology training in Sub-Saharan Africa with free access to high quality online courses. Register here: https://pulse.ly/7n75afapml 📅Deadline: 15 September 2025. #MedicalEducation

NEW Correspondence—Aspirin desensitisation in pregnant individuals with autoimmune disease bit.ly/3Vq74rN #Medsky #Rheumsky

NEW Correspondence—From whole-brain metrics to circuit-specific precision: advancing fMRI biomarkers for TNF inhibitor response in rheumatoid arthritis Letter ➡️ bit.ly/4lWADw7 Authors' reply➡️ bit.ly/428azXB Linked to this Article ➡️ bit.ly/4lSNkIf #Medsky #Rheumsky

In our Sept editorial we discuss the complexities of ILD in rheumatic diseases bit.ly/4mR9wmR #Medsky #Rheumsky

Our September issue is live! Including research on #lowbackpain, dual JAK and ROCK inhibition in #rheumatoidarthritis, tapering of TNF inhibitors in #psoriaticarthritis & axial #spondyloarthritis, plus much more! thelancet.com/journals/lan... Cover by Sara Gironi Carnevale #Medsky #Rheumsky

NEW Correspondence—Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus Letter ➡️ bit.ly/3JABcOr Authors' reply ➡️ bit.ly/45kBsd5 Linked to this Article ➡️ bit.ly/3HD17o9

NEW RESEARCH—Personalised gait retraining for medial compartment knee #osteoarthritis: a randomised controlled trial bit.ly/4luS5aO @utah.edu #ASB2025 #Medsky #Rheumsky #BiomechSky

NEW Essay—Expanding the rheumatology lens: should we embrace POTS and post-infectious syndromes? bit.ly/3J82c7R #Medsky #Rheumsky

NEW Correspondence—Preload deficiency as a treatable cause of fatigue and exercise intolerance in #SLE bit.ly/3URufuM #Medsky #Rheumsky

NEW RESEARCH—Cognitive functional therapy, with or without movement sensor biofeedback, produced sustained effects at 3 years versus usual care for people with chronic disabling low back pain bit.ly/3Jm6nwP #Medsky #Rheumsky

NEW RESEARCH—Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip #osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial bit.ly/4mm0iia #Medsky #Rheumsky #Physiosky

Aiming for 7,000 daily steps can reduce risk of chronic diseases, cognitive decline, and death, finds new study. Explore the research in @thelancetph.bsky.social: tinyurl.com/mrvd9uyt

NEW RESEARCH—Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial bit.ly/3GJHgDv #Medsky #Rheumsky

NEW in our August issue—We highlight some of the exciting research developments presented at #EULAR2025 bit.ly/4kYeWeu

Our August issue is live! Including research on patient-reported outcomes in #PMR, maternal autoantibodes and fetal congenital heart block, occupational therapist-led care for hand #OA, and CNS activation in #RA, plus much more! www.thelancet.com/journals/lan... Cover by Sara Gironi Carnevale

NEW Patient voice—Dismissed! My long diagnostic odyssey to Ehlers–Danlos syndrome bit.ly/40tctkR #Medsky #Rheumsky

NEW RESEARCH—Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study bit.ly/4lgcfWx #Medsky #Rheumsky @koraytascilar.bsky.social

Translating AI innovation into clinical practice Read our July editorial www.thelancet.com/journals/lan...

We are a world-leading rheumatology journal While a partial measurement of our impact, we are pleased to share our Impact Factor of 16·4 and CiteScore of 24·3. hubs.li/Q03vf6pR0 #Medsky #Rheumsky

#Biologics is commonly used in #rheumatology but inequitable access exists in the #AsiaPacifc & #LMICs. Our joint podcast with @thelancetrheum.bsky.social with Prof Xue Li discusses the factors that delay access in Asia, any #policy changes & role of #biosimilars. 🔊Listen now: tinyurl.com/ys5x7uxn

NEWS—Debate over interventional procedures for chronic spine pain A clinical guideline published in @bmj.com has sparked controversy for recommending against the use of common interventional procedures for chronic spine pain Find out more 👉https://bit.ly/3Tmnwsb #Medsky #Rheumsky